Strive

ASST · NASDAQ

$27.06+$1.52 (+5.95%)TodayMarket closed ·
Prev close $25.54

About ASST

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. The company is headquartered in Dallas, Texas and currently employs 28 full-time employees. The company went IPO on 2023-02-03. The firm is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The firm's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.

Employees
28
Headquarters
Dallas, Texas
Listed
Feb 3, 2023
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Strive executives
NameTitleSince
Matthew Cole—2025
Arman Sarkhani——
Benjamin Pham—2025
Benjamin Werkman—2025
Arshia Sarkhani—2021
Logan Beirne—2025
Avik Roy—2025
Shirish Jajodia——
James Lavish——
Jonathan Macey——
Mahesh Ramakrishnan——
Pierre Rochard——
Eric Semler——

Revenue by product and region

Fiscal year ended Mar 31, 2026: $2.76M total revenue

By product

  • Medical device revenues$1.37M49.6%
  • Investment advisory fees$1.35M48.8%
  • Other revenue$43.00K1.6%

Similar companies

Companies in the same industry as Strive

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.